Stoller afferent nerve stimulation in woman with therapy resistant over active bladder; a 1-year follow up

Nuhoğlu, Barış; Fidan, Vecihi; Ayyıldız, Ali; Ersoy, Erim; Germíyanoğlu, Cankon

doi:10.1007/s00192-005-1370-x

Cited by 29 publications

(31 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have been published evaluating the effects of PTNS on OAB [13-19]. According to these studies, the overall percentage of patients classified as “successfully treated” was 54.5-79.5%.…”

Section: Resultsmentioning

confidence: 99%

Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review

et al. 2013

View full text Add to dashboard Cite

BackgroundPercutaneous Tibial Nerve Stimulation (PTNS) has been proposed for the treatment of overactive bladder syndrome (OAB), non-obstructive urinary retention (NOUR), neurogenic bladder, paediatric voiding dysfunction and chronic pelvic pain/painful bladder syndrome (CPP/PBS). Despite a number of publications produced in the last ten years, the role of PTNS in urinary tract dysfunctions remains unclear. A systematic review of the papers on PTNS has been performed with the aim to better clarify potentialities and limits of this technique in the treatment of OAB syndrome and in other above mentioned urological conditions.MethodsA literature search using MEDLINE and ISI web was performed. Search terms used were “tibial nerve” and each of the already mentioned conditions, with no time limits. An evaluation of level of evidence for each paper was performed.ResultsPTNS was found to be effective in 37-100% of patients with OAB, in 41-100% of patients with NOUR and in up to 100% of patients with CPP/PBS, children with OAB/dysfunctional voiding and patients with neurogenic pathologies. No major complications have been reported.Randomized controlled trials are available only for OAB (4 studies) and CPP/PBS (2 studies). Level 1 evidence of PTNS efficacy for OAB is available. Promising results, to be confirmed by randomized controlled studies, have been obtained in the remaining indications considered.ConclusionsPTNS is an effective and safe option to treat OAB patients. Further studies are needed to assess the role of PTNS in the remaining indications and to evaluate the long term durability of the treatment. Further research is needed to address several unanswered questions about PTNS.

show abstract

Section: Resultsmentioning

confidence: 99%

Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review

et al. 2013

View full text Add to dashboard Cite

show abstract

“…This observation explains the carryover effect following a cycle of stimulation, in which patients report an extended clinical effect after initial treatment for a variable period of time. However, clinical efficacy was only maintained for longer than one year of follow-up in less than 22% of participants [13]. In fact, it has been shown that over a oneyear period at least two, 12-week cycles are recommended to ensure sustained clinical effect for three months, on average [14].…”

Section: Commentsmentioning

confidence: 98%

Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial

Manrı́quez

Guzmán

Naser

et al. 2016

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

“…The responders with positive response of PTNS were also shown in several studies from 2005 to 2006, ranging from 37.3% to 81.8%. [27][28][29][30][31] The terms of responders were more than 50% reduction in symptoms including urgency, frequency, incontinence episodes, 27,29,30 complete recovery after treatment, 28 overall treatment response rate 31 and subjective feeling of improvement. 27 In an RCT by Finazzi Agrò et al 32 comparing PTNS and sham procedure, there were 75% and 0% patients with 50% reduction After its approval by FDA in 2007, PTNS showed considerable promise in the management of OAB.…”

Section: Efficacymentioning

confidence: 99%

Management of overactive bladder review: the role of percutaneous tibial nerve stimulation

Wibisono

Rahardjo

2017

Med J Indones

View full text Add to dashboard Cite

ABSTRAK ABSTRACTOveractive bladder (OAB) is a common condition that is experienced by around 455 million people (11% of the world population) and associated with significant impact in patients' quality of life. The first line treatments of OAB are conservative treatment and anti-muscarinic medication. For the refractory OAB patients, the treatment options available are surgical therapy, electrical stimulation, and botulinum toxin injection. Among them, percutaneous tibial nerve stimulation (PTNS) is a minimally invasive option that aims to stimulate sacral nerve plexus, a group of nerve that is responsible for regulation of bladder function. After its approval by food and drug administration (FDA) in 2007, PTNS revealed considerable promise in OAB management. In this review, several non-comparative and comparative studies comparing PTNS with sham procedure, anti-muscarinic therapy, and multimodal therapy combining PTNS and anti-muscarinic had supportive data to this consideration.

show abstract

Stoller afferent nerve stimulation in woman with therapy resistant over active bladder; a 1-year follow up

Abstract: SANS treatment has a short-term positive effect in patients with resistant overactive bladder. However, it was also established that efficacy was maintained at 1 year in only 23% of subjects.

Cited by 29 publications

References 12 publications

Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review

Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review

Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial

Management of overactive bladder review: the role of percutaneous tibial nerve stimulation

Contact Info

Product

Resources

About